Effect of Food-derived Active Components on Digestive Tract Health in Adults with Irritable Bowel Syndrome

NANot yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2025

Conditions
Irritable Bowel Syndrome - Diarrhoea
Interventions
DIETARY_SUPPLEMENT

Prebiotic_L

subject will receive a low-dosage (1\*10\^5) of Bifidobacterium. animalis subsp.Lactis A6 Strain

DIETARY_SUPPLEMENT

resveratrol_L

subject will receive a low-dosage (300mg/d) of resveratrol

DIETARY_SUPPLEMENT

Prebiotic_M

subject will receive a medium-dosage (1\*10\^8) of Bifidobacterium. animalis subsp.Lactis A6 Strain

DIETARY_SUPPLEMENT

Prebiotic_H

subjects will receive a high-dosage (1\*10\^10) of Bifidobacterium. animalis subsp.Lactis A6 Strain

DIETARY_SUPPLEMENT

resveratrol_H

subject will receive a low-dosage (600mg/d) of resveratrol

OTHER

placebo_Bif

subjects will receive placebo (one look-alike sunbstance that contains no prebiotics)

OTHER

placebo_resveratrol

subjects will receive placebo (one look-alike sunbstance that contains no resveratrol)

Trial Locations (1)

100083

Peking University, Beijing

All Listed Sponsors
lead

Peking University

OTHER

NCT06779214 - Effect of Food-derived Active Components on Digestive Tract Health in Adults with Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter